MSB 3.56% $1.17 mesoblast limited

Ann: P3 Trial of MSB's Cell Therapy in CHF Completes Recruitment, page-6

  1. 3,891 Posts.
    lightbulb Created with Sketch. 1320
    So you already knew that Revascor is able to prevent Terminal Cardiac Events or hospitalisations for 3 years?  In patients who were very sick?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.